Blog

Nina Niu Sanford: Nice editorial urging caution in patients with near CR after total neoadjuvant therapy in rectal cancer

Photo Nina Niu Sanford from UT Southwestern Medical Center

May 11, 2024, 12:05

Nina Niu Sanford: Nice editorial urging caution in patients with near CR after total neoadjuvant therapy in rectal cancer

Nina Niu Sanford, Assistant Professor of Radiation Oncology at UT Southwestern Medical Center, shared a post on X:

“Nice editorial in JAMA Oncology today urging caution in pts w near CR after total neoadjuvant therapy in rectal cancer.

Reported rates of conversion from nCR to cCR vary widely from 39% to 100%!

Completely agree these patients should be counseled re: uncertainty of pursuing organ preservation, closely followed, & eventually better stratification needed for this biologically heterogeneous subgroup.”

Source: Nina Niu Sanford/X

Biologically Heterogeneous Subgroup cancer Clinical Follow-up complete response editorial JAMA Oncology Medical Uncertainty near complete response Nina Niu Sanford OncoDaily Oncology organ preservation patient counseling rectal cancer Research Total Neoadjuvant Therapy treatment decision Treatment Stratification

FDA approval: Pembrolizumab for HER2 positive gastric or GEJ adenocarcinoma expressing PD-L1 (CPS ≥1): KEYNOTE-811 Trial

Changing the Future of Adolescent and Young Adult Cancer Care

OncoDaily Launches New Social Channel on Telegram – @OncoDaily

In Memory of Chadwick Boseman and His Colon Cancer Battle

Groundbreaking Canadian Cancer Society-funded research aims to reshape the future of advanced cancer